Lung Cancer Challenges in Resectable Disease: It's a Whole New World

Moderator(s)

• 

  Kyle Mitchell, MD, MSc

  Assistant Professor
  University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Elliot Servais, MD

  Associate Professor, Thoracic Surgeon
  Lahey Hospital & Medical Center
  Wellesley, Massachusetts, United States

Presentations:

• 11:30am – 11:40am PT

  Synchronous Primary Stage I Non-Small Cell Lung Cancer: Trends in Management and Survival
  

  Presenting Author: Nikki E. Rossetti, MD, MS – Washington University School of Medicine
• 11:40am – 11:50am PT

  Not All T4 Patients Should Be Considered Equal: NSCLC Heterogeneity and Surgical Outcome
  

  Presenting Author: Xun Luo, MD, MPH – West Virginia University
• 11:50am – 12:00pm PT

  Reassessing Perioperative Risks: Impact of Neoadjuvant Therapy on Mortality in Pneumonectomy
  

  Presenting Author: Christina S. Boutros, DO – University Hospitals Cleveland Medical Center/ Case Western Reserve University
• 12:00pm – 12:10pm PT

  Delayed Surgery Decreases Overall Survival in Early-Stage Non-Small Cell Lung Cancer: A Propensity Matched Cohort Analysis
  

  Presenting Author: Alyssa Murillo, MD, MS, MA.Ed (she/her/hers) – University of California San Francisco (UCSF)
• 12:10pm – 12:20pm PT

  Utilization and Survival Outcomes of Surgical Resection for Clinical Stage IIIB Non-Small Cell Lung Cancer
  

  Presenting Author: Ryan C. Jacobs, MD, MS (he/him/his) – Northwestern University Feinberg School of Medicine
• 12:20pm – 12:30pm PT

  Social Vulnerability Index Is Associated with Time-to-Treatment in Resectable Non-Small Cell Lung Cancer
  

  Presenting Author: Arsalan A. Khan, MD (he/him/his) – Rush University Medical Center
• 12:30pm – 12:40pm PT

  Clinical Stage II Non-Small Cell Lung Cancer: Can We “Just Give Adjuvant Therapy”?
  

  Presenting Author: Rajika Jindani, MD, MPH (she/her/hers) – Montefiore Medical Center/ Albert Einstein College of Medicine
• 12:40pm – 12:46pm PT

  Debate: No—Neoadjuvant Therapy for Node-Negative NSCLC
  

  Invited Speaker: Raja Flores, MD – Mount Sinai School of Medicine
• 12:46pm – 12:52pm PT

  Debate: Yes—Neoadjuvant Therapy for Node-Negative NSCLC
  

  Invited Speaker: Nathaniel R. Evans, III, MD (he/him/his) – Thomas Jefferson University
• 12:52pm – 1:00pm PT

  Discussion